{"meta":{"query_hash":"6f2a9cc7c515","filters":{"venue":"European Oncology & Haematology"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6f2a9cc7c515","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Oncology+%26+Haematology"},"results":[{"id":"W168572226","doi":"10.17925/eoh.2012.08.3.148","title":"Weighing Bone-targeted Treatment Options for Patients with Solid Tumours and Skeletal Complications from Metastatic Disease","year":2012,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Clinical trial; Intensive care medicine; Oncology; Physical therapy; Internal medicine; Nursing","score_opus":0.028848135053214572,"score_gpt":0.3180163214109421,"score_spread":0.2891681863577275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W168572226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20440966,0.60955036,0.0037177238,0.13541648,0.002337318,0.0003414703,0.00044730693,0.000058721256,0.043720897],"genre_scores_gemma":[0.7289612,0.23936148,0.009825005,0.012954371,0.0039494196,0.00027104552,0.00025529743,0.000021831991,0.004400399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906343,0.00042676035,0.0001073682,0.000036035693,0.00031716994,0.00004922007],"domain_scores_gemma":[0.998931,0.00055125257,0.00022399423,0.000020940564,0.00011079649,0.00016204662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013811818,0.00022690336,0.0006091601,0.00053528236,0.00037813504,0.00081644516,0.00027063058,0.0007931628,0.004717505],"category_scores_gemma":[0.005632006,0.000088536726,0.00049880275,0.00046528757,0.00029814627,0.0011550543,0.0006041497,0.0009545183,0.00043961257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018913962,0.0004381858,0.013358847,0.0024931147,0.0004488976,0.00051866955,0.00033498328,0.0013246445,0.0020127618,0.0044387197,0.016645001,0.95609474],"study_design_scores_gemma":[0.004645249,0.021782365,0.16906784,0.015633658,0.0044935704,0.011846119,0.0062139616,0.0053378628,0.005714616,0.05897754,0.69602174,0.00026542463],"about_ca_topic_score_codex":0.00050256925,"about_ca_topic_score_gemma":0.002139963,"teacher_disagreement_score":0.004717505,"about_ca_system_score_codex":0.0004990984,"about_ca_system_score_gemma":0.00073937175,"threshold_uncertainty_score":0.015781581},"labels":[],"label_agreement":null},{"id":"W2380744455","doi":"10.17925/ohr.2015.11.01.57","title":"Gastrointestinal Stromal Tumors (GIST)—Paving the Way for Modern Oncology—Epidemiology, Diagnosis, Treatment","year":2015,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; GiST; Regorafenib; Imatinib; Sunitinib; Oncology; Internal medicine; Stromal tumor; Imatinib mesylate; Surgery; Radiology; Stromal cell; Colorectal cancer; Cancer","score_opus":0.19027670565616578,"score_gpt":0.41336039842027045,"score_spread":0.22308369276410467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2380744455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021875303,0.8930031,0.0034518444,0.06728752,0.002305155,0.000044660643,0.00034936448,0.0001068595,0.011576144],"genre_scores_gemma":[0.13089663,0.8451156,0.005354981,0.006975349,0.008760306,0.00003412065,0.0005268197,0.000026831125,0.0023093335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959344,0.00014294554,0.00006698866,0.000054834964,0.000106279374,0.00003549783],"domain_scores_gemma":[0.99884194,0.00029938162,0.00030566915,0.00005451499,0.00028934737,0.00020914839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010132998,0.00026246317,0.00050130184,0.0015181552,0.00036267095,0.0013655383,0.00036164693,0.0009002824,0.0023821658],"category_scores_gemma":[0.0018926348,0.00015040641,0.00019150195,0.0019681754,0.00093308446,0.0026702897,0.0007122603,0.0017052476,0.00067675323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015627021,0.00013365084,0.042667728,0.00140788,0.00005863056,0.0011276985,0.00014268488,0.00045192766,0.0017888682,0.015574273,0.04698475,0.8895056],"study_design_scores_gemma":[0.00005548751,0.0004936209,0.09642013,0.0040275296,0.0001426709,0.030138023,0.0015877341,0.0014626451,0.0011923721,0.03272684,0.83164,0.000113000904],"about_ca_topic_score_codex":0.0016212504,"about_ca_topic_score_gemma":0.0016258244,"teacher_disagreement_score":0.0023821658,"about_ca_system_score_codex":0.0010275675,"about_ca_system_score_gemma":0.0015512296,"threshold_uncertainty_score":0.007969141},"labels":[],"label_agreement":null},{"id":"W2499395398","doi":"10.17925/eoh.2007.0.2.32","title":"Treatment of Multiple Myeloma Patients Who Have Received at Least One Prior Therapy","year":2007,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine","score_opus":0.054319180231085354,"score_gpt":0.33647497275216726,"score_spread":0.2821557925210819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499395398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7682382,0.09098987,0.0036537496,0.0153437415,0.002447106,0.0015493126,0.002417546,0.00040577518,0.11495476],"genre_scores_gemma":[0.9106478,0.035697713,0.0047530243,0.01019791,0.0018656725,0.0008322037,0.0031809881,0.00003603947,0.032788616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999887,0.000023700248,0.000010852358,0.000016340055,0.000028644285,0.000033542485],"domain_scores_gemma":[0.99986315,0.000015633195,0.000020525238,0.000008165325,0.000021370204,0.000071169845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016323605,0.00021237199,0.0007428355,0.00019836816,0.0007136858,0.00028476273,0.00023523202,0.00051920017,0.008122549],"category_scores_gemma":[0.00042085056,0.00007532754,0.00047298538,0.0003195105,0.00013103505,0.00022775018,0.000288041,0.00063255936,0.0022322512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009157715,0.0053024315,0.14526992,0.0020694877,0.00047585845,0.013921095,0.00064517267,0.00051593344,0.036218047,0.001321083,0.10890513,0.6761982],"study_design_scores_gemma":[0.003810784,0.015515149,0.34069675,0.0009204183,0.0007797079,0.044939753,0.00048616694,0.0011619985,0.009845708,0.001811541,0.57995254,0.00007945864],"about_ca_topic_score_codex":0.00051271956,"about_ca_topic_score_gemma":0.0012988417,"teacher_disagreement_score":0.008122549,"about_ca_system_score_codex":0.00017983002,"about_ca_system_score_gemma":0.00038154898,"threshold_uncertainty_score":0.027172685},"labels":[],"label_agreement":null},{"id":"W2559226961","doi":"10.17925/eoh.2016.12.02.79","title":"Treatment Update for Women with Hormone Receptor-positive Advanced Breast Cancer","year":2016,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca","keywords":"Anastrozole; Medicine; Fulvestrant; Breast cancer; Oncology; Internal medicine; Hormone receptor; Cancer; Hormonal therapy; Hormone therapy; Hormone; Gynecology; Tamoxifen","score_opus":0.004953099816584024,"score_gpt":0.2498291850781909,"score_spread":0.2448760852616069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559226961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003988598,0.747582,0.0023734302,0.16702817,0.024206204,0.0001880663,0.0018077187,0.0004761589,0.05234968],"genre_scores_gemma":[0.02739728,0.79100806,0.011854872,0.09517065,0.027421152,0.000495406,0.0045832186,0.000106430576,0.041962847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993766,0.00020888569,0.00011490033,0.000033957152,0.00022221541,0.000043574164],"domain_scores_gemma":[0.99759465,0.00087636535,0.00035040808,0.00004863742,0.00087599683,0.00025383235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013746048,0.0004227875,0.00088102336,0.0009993165,0.0004248607,0.0010324282,0.000721436,0.002386965,0.0083922865],"category_scores_gemma":[0.004096049,0.00022536048,0.000623898,0.0011498448,0.00021215442,0.0011304424,0.00048574648,0.002976129,0.0034964872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029291783,0.00010822463,0.0008631091,0.002190168,0.00005952704,0.00034108266,0.000049261722,0.00015151179,0.0006387321,0.001125803,0.37750468,0.6166749],"study_design_scores_gemma":[0.000058631573,0.00012598107,0.0017838716,0.0010749159,0.00009055023,0.0007766385,0.000039941337,0.00007472278,0.00011281653,0.00040063684,0.9954526,0.000008637409],"about_ca_topic_score_codex":0.0019408062,"about_ca_topic_score_gemma":0.0072557884,"teacher_disagreement_score":0.0083922865,"about_ca_system_score_codex":0.000811927,"about_ca_system_score_gemma":0.0013663743,"threshold_uncertainty_score":0.02807498},"labels":[],"label_agreement":null},{"id":"W2776607461","doi":"10.17925/eoh.2017.13.02.147","title":"Bmi1 – A Path to Targeting Cancer Stem Cells","year":2017,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"BMI1; PRC2; Hox gene; Cancer research; Cancer stem cell; Polycomb-group proteins; Homeotic gene; Stem cell; Radioresistance; Repressor; Biology; Cancer; EZH2; Cell biology; Genetics; Gene; Histone; Transcription factor; Cell culture","score_opus":0.02527399511552401,"score_gpt":0.32085641903218115,"score_spread":0.2955824239166571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776607461","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.107641295,0.6555872,0.072968826,0.082676075,0.0075266757,0.00043809565,0.001933828,0.0017765986,0.06945138],"genre_scores_gemma":[0.45074734,0.41140595,0.0332539,0.021337282,0.0026881027,0.0004360958,0.0019310791,0.00020194262,0.07799825],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998877,0.000020122196,0.0000049173163,0.000019924497,0.000046400215,0.000020952664],"domain_scores_gemma":[0.99990535,0.00001602152,0.000016555041,0.00000870067,0.000023858749,0.000029494657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033299866,0.00026489949,0.00026036584,0.00031407244,0.0001800802,0.00056821184,0.00043741282,0.00052341085,0.0030663337],"category_scores_gemma":[0.00029801755,0.00017073353,0.00018520968,0.00016442453,0.00044904635,0.00055756007,0.00046880599,0.0026008687,0.0012743864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008100776,0.00027240597,0.000940108,0.0017011302,0.00012444754,0.00034858368,0.00022583612,0.0011233462,0.44527325,0.088330545,0.054685913,0.40616447],"study_design_scores_gemma":[0.00016202114,0.0007853558,0.0013948294,0.00017572205,0.00004704735,0.00069119554,0.000047797716,0.0006988344,0.10707557,0.013881498,0.8750111,0.000029025527],"about_ca_topic_score_codex":0.00035459283,"about_ca_topic_score_gemma":0.0009546657,"teacher_disagreement_score":0.0030663337,"about_ca_system_score_codex":0.00047703218,"about_ca_system_score_gemma":0.00041801194,"threshold_uncertainty_score":0.0102579},"labels":[],"label_agreement":null}]}